XML 49 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring and Related Charges (Tables)
9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Liabilities

The following table summarizes the change in the Company’s restructuring and other related liabilities for the nine months ended September 30, 2024 (in thousands):

 

 

 

Severance
and other
employee-
related
benefits
(1)

 

 

Facility
Costs

 

 

Other(2)

 

 

Total

 

Balance at December 31, 2023

 

$

825

 

 

$

 

 

$

 

 

$

825

 

Restructuring and related charges

 

 

9,522

 

 

 

2,108

 

 

 

744

 

 

 

12,374

 

Cash payments

 

 

(7,806

)

 

 

(2,108

)

 

 

(744

)

 

 

(10,658

)

Balance at September 30, 2024

 

$

2,541

 

 

$

 

 

$

 

 

$

2,541

 

 

(1)
Restructuring liabilities are recorded in accrued liabilities on the condensed consolidated balance sheets. Substantially all severance and other employee-related benefits related to ongoing benefit arrangements and were recorded pursuant to ASC 712.
(2)
Other restructuring liabilities are comprised mainly of sublease commissions and are recorded in other accrued liabilities on the condensed consolidated balance sheets.

The Company’s restructuring and related charges by segment and corporate were as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Restructuring:

 

 

 

 

 

 

 

 

 

 

 

 

Proteomics

 

$

 

 

$

213

 

 

$

 

 

$

691

 

Genomics

 

 

 

 

 

70

 

 

 

 

 

 

629

 

Corporate expenses

 

 

2,341

 

 

 

1,715

 

 

 

12,374

 

 

 

4,095

 

Total restructuring and related charges

 

$

2,341

 

 

$

1,998

 

 

$

12,374

 

 

$

5,415